MB

Michael Bradley

Abbott: 12 patents #503 of 5,431Top 10%
SP Syros Pharmaceuticals: 7 patents #5 of 53Top 10%
AV Abb Vie: 5 patents #334 of 1,257Top 30%
DI Dana-Farber Cancer Institute: 3 patents #302 of 1,343Top 25%
AB Array Biopharma: 1 patents #256 of 335Top 80%
LF Longview Fibre: 1 patents #4 of 12Top 35%
Overall (All Time): #127,342 of 4,157,543Top 4%
29
Patents All Time

Issued Patents All Time

Showing 25 most recent of 29 patents

Patent #TitleCo-InventorsDate
12240869 Inhibitors of cyclin-dependent kinase 7 (CDK7) Jason J. Marineau, Claudio Edmundo Chuaqui, Stephane Ciblat, Anzhelika Kabro 2025-03-04
11918592 Inhibitors of cyclin dependent kinase 7 (CDK7) Jason J. Marineau, Claudio Edmundo Chuaqui, Stephane Ciblat, Anzhelika Kabro, Henri Piras +2 more 2024-03-05
11040957 Heteroaromatic compounds useful for the treatment of proliferative diseases Stephane Ciblat, Patrick Deroy, Nathanael S. Gray, Melissa Leblanc, Jason J. Marineau +10 more 2021-06-22
10906889 Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) Nathanael S. Gray, Tinghu Zhang, Stephane Ciblat, Melissa Leblanc, Jason J. Marineau +8 more 2021-02-02
10738067 Inhibitors of cyclin-dependent kinase 7 (CDK7) Jason J. Marineau, Claudio Edmundo Chuaqui, Stephane Ciblat, Anzhelika Kabro 2020-08-11
10519135 Inhibitors of cyclin-dependent kinase 7 (CDK7) Kevin Sprott, Jason J. Marineau, Darby Schmidt, Stephane Ciblat, M. Arshad Siddiqui +8 more 2019-12-31
10329276 Salt and crystalline forms thereof of a drug Geoff G. Zhang, David M. Barnes, Rodger F. Henry 2019-06-25
10106526 Inhibitors of cyclin-dependent kinase 7 (CDK7) Kevin Sprott, Jason J. Marineau, Darby Schmidt, Stephane Ciblat, M. Arshad Siddiqui +8 more 2018-10-23
10059690 Inhibitors of cyclin-dependent kinase 7 (CDK7) Stephane Ciblat, Kevin Sprott, Dana K. Winter, Amy Ripka, Dansu Li +8 more 2018-08-28
10047070 Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) Nathanael S. Gray, Tinghu Zhang, Stephane Ciblat, Melissa Leblanc, Jason J. Marineau +8 more 2018-08-14
9873681 Salt and crystalline forms thereof of a drug Geoff G. Zhang, David M. Barnes, Rodger F. Henry 2018-01-23
9539250 Salt and crystalline forms thereof of a drug Geoff G. Zhang, David M. Barnes, Rodger F. Henry 2017-01-10
8969569 Salt and crystalline forms thereof of a drug Geoff G. Zhang, David M. Barnes, Rodger F. Henry 2015-03-03
8841455 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors Mark Laurence Boys, Robert Kirk DeLisle, D. David Hennings, April L. Kennedy, Fredrik P. Marmsater +7 more 2014-09-23
8648093 Salt and crystalline forms thereof of a drug Geoff G. Zhang, David M. Barnes, Rodger F. Henry 2014-02-11
8273892 Salt and crystalline forms thereof of a drug Geoff G. Zhang, David M. Barnes, Rodger F. Henry 2012-09-25
8252813 Salt and crystalline forms thereof of a drug Geoff G. Zhang, David M. Barnes, Rodger F. Henry 2012-08-28
7728143 Salt and crystalline forms thereof of a drug Geoff G. Zhang, David M. Barnes, Rodger F. Henry 2010-06-01
7592466 Ureas having antiangiogenic activity Fortuna Haviv, Daryl Sauer 2009-09-22
7169888 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity Fortuna Haviv 2007-01-30
7122625 Hexa-, hepta-, and octapeptides having antiangiogenic activity Fortuna Haviv 2006-10-17
7067490 Hepta-, Octa-and nonapeptides having antiangiogenic activity Fortuna Haviv 2006-06-27
7037897 TRI-, TETRA-, and penta-peptides having antiangiogenic activity Fortuna Haviv 2006-05-02
7001984 Di-, tri-, and tetra-peptides having antiangiogenic activity Fortuna Haviv 2006-02-21
6777535 N-alkylated peptides having antiangiogenic activity Fortuna Haviv, Jack Henkin, Douglas M. Kalvin 2004-08-17